Document Detail


Cerebral venous thrombosis and activated protein C resistance.
MedLine Citation:
PMID:  8841319     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Activated protein C resistance (APC-R) due to factor V Leiden has recently been established as an important risk factor for cerebral venous thrombosis (CVT). The clinical significance of abnormal or borderline functional APC-R in the absence of factor V Leiden is uncertain. Our observations suggest that APC-R due to mechanisms other than factor V Leiden may also contribute to the development of CVT. CASE DESCRIPTIONS: We describe three women who had superior sagittal and lateral sinus thrombosis while taking oral contraceptives and had a number of additional risk factors for CVT. Each had APC-R for different reasons. CONCLUSIONS: Inherited thrombophilia, including APC-R, should be looked for in all patients with CVT. Functional APC-R is a highly prevalent coagulopathy, but the reasons for this abnormality are diverse; abnormal and borderline functional APC-R results should be supplemented by DNA analysis for the presence of factor V Leiden.
Authors:
D A Dulli; C C Luzzio; E C Williams; H S Schutta
Related Documents :
25213079 - Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases.
9609219 - Factor v leiden is not a risk factor for arterial vascular disease in the elderly: resu...
17581329 - Upper extremity deep vein thrombosis after suspension of progesterone-only oral treatment.
851299 - The laboratory diagnosis of the carrier state for classic hemophilia.
19786939 - Polymorphisms in exons 6 and 7 of the abo locus and their association with venous throm...
15540709 - Risk factors for pulmonary embolism in an irish patient cohort.
2961909 - A case-control study of breast cancer and hormonal contraception in costa rica.
18661489 - Acceptance of preimplantation genetic diagnosis for beta-thalassemia in lebanese women ...
24860819 - Association between two common polymorphisms and risk of hepatocellular carcinoma: evid...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  27     ISSN:  0039-2499     ISO Abbreviation:  Stroke     Publication Date:  1996 Oct 
Date Detail:
Created Date:  1996-11-15     Completed Date:  1996-11-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1731-3     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Wisconsin-Madison Medical School 53792, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anticoagulants / therapeutic use
Cerebral Veins
Contraceptives, Oral / adverse effects
Drug Resistance
Female
Humans
Intracranial Embolism and Thrombosis / drug therapy,  physiopathology*
Partial Thromboplastin Time
Protein C / analysis,  physiology*
Protein S / analysis
Risk Factors
Sinus Thrombosis, Intracranial / drug therapy,  etiology,  physiopathology
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Contraceptives, Oral; 0/Protein C; 0/Protein S; 81-81-2/Warfarin
Comments/Corrections
Comment In:
Stroke. 1996 Oct;27(10):1719-20   [PMID:  8841316 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous ...
Next Document:  Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ...